ACW 4.41% 7.1¢ actinogen medical limited

renewed interest, page-25

  1. 351 Posts.
    lightbulb Created with Sketch. 51
    Initially the market thought Biogen's Alzheimers trial results were good but after the readout of the data there seems to be more questions...
    This could impact ACW SP possitively.
    DYOR
    https://uk.finance.yahoo.com/news/biogen-eisai-sink-much-awaited-150700734.html?.tsrc=applewf
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.